2019
DOI: 10.1016/j.neubiorev.2019.04.010
|View full text |Cite
|
Sign up to set email alerts
|

Stress, epigenetics and depression: A systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
139
0
12

Year Published

2019
2019
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 267 publications
(153 citation statements)
references
References 59 publications
2
139
0
12
Order By: Relevance
“…Depression is a common mental disorder worldwide [1]. The pathogenesis of depression is not completely clear [2]. In addition to serotonin (5-HT) knowledge, immune activation and the production of inflammatory cytokines, such as IL-1β, IL-6, TNFα, are involved in depression because its symptomatology includes some behaviors that also occur during chronic inflammatory stress [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%
“…Depression is a common mental disorder worldwide [1]. The pathogenesis of depression is not completely clear [2]. In addition to serotonin (5-HT) knowledge, immune activation and the production of inflammatory cytokines, such as IL-1β, IL-6, TNFα, are involved in depression because its symptomatology includes some behaviors that also occur during chronic inflammatory stress [3][4][5][6].…”
Section: Introductionmentioning
confidence: 99%
“…Furthermore, research teams of Park et al [23] and Misra et al [24] have confirmed that stress-related epigenetic changes in the following genes: NRC31, SLCA4, BDNF, FKBP5, SKA2, OXTR, LINGO3, POU3F1, ID3, TPPP, GRIN1, and ITGB1 correlate with the occurrence of depression (respectively, Misra et al, [24]). Additionally, it has been noted that negative experiences from childhood, through epigenetic changes, may have a significant impact on the effectiveness of depression pharmacotherapy [25].…”
Section: Epigenetics In Depressionmentioning
confidence: 93%
“…The role of specific classes of long noncoding RNAs in resiliency or susceptibility to develop depression with a reciprocal response to antidepressant treatment is underlined [83]. Epigenetic changes in the signalling pathway of glucocorticosteroids (e.g., NR3C1, FKBP5), with regard to serotonergic neurotransmission (e.g., SLC6A4) and in the area of genes encoding neurotrophic factors (e.g., BDNF), seem to be the most promising therapeutic targets for future research [23,84].…”
Section: Further Directions Ofmentioning
confidence: 99%
“…maternal depression, malnutrition) has been associated with peripheral DNA methylation outcome later in life [ 18 ▪ , 20 , 22 24 ]. Although the studies in question are heterogenous with respect to methodology and results [ 18 ▪ , 23 ], available findings point to the potentials of epigenetic processes to constitute molecular mechanisms that could link environmental impacts, experienced at various moments throughout the life cycle (perinatal, childhood and adult) to mental-health outcomes, including eating disorders [ 8 , 18 ▪ , 23 ]. Importantly, methylation of some genes can also be altered by psychotherapeutic, nutritional or pharmacologic interventions [ 25 , 26 ▪▪ ], which raises the promise that changes in DNA methylation could serve as a marker for disease risk, staging, prognosis or therapeutic response.…”
Section: What Is Dna Methylation?mentioning
confidence: 99%